Back to Course
Acquired Heart Disease
0% Complete
0/0 Steps
-
Dog Breed Predilictions
-
Myxomatous Mitral Valve Degeneration5 Topics
-
Cardiomyopathies
-
Canine Dilated Cardiomyopathy5 Topics
-
Feline Dilated Cardiomyopathy5 Topics
-
Feline Thromboembolic Disease
-
Feline Hypertrophic Cardiomyopathy5 Topics
-
Feline Restrictive Cardiomyopathy
-
Other Feline Cardiomyopathies
-
Feline Hyperthyroidism5 Topics
-
Boxer Cardiomyopathy
-
Canine Hypertrophic Cardiomyopathy
-
Pericardial Disorders
-
Pericardial Effusion6 Topics
-
Constrictive Pericardial Disease
-
Feline Pericardial Disease
-
Bacterial Endocarditis5 Topics
-
Canine Heartworm Disease6 Topics
-
Feline Heartworm Disease
-
Occult Heartworm Disease5 Topics
Lesson 20,
Topic 4
In Progress
Treatment
Lesson Progress
0% Complete
- Supportive Therapy:
- Aspirin: previously advocated either prior to adulticide therapy or concomitant with adulticide therapy to reduce the pulmonary artery endothelial and medial changes (so-called pulmonary arteritis) is no longer recommended. It may even be contraindicated.
- Diuretic therapy: relieve pulmonary edema and fluid overload.
- Marked restriction in exercise.
- Corticosteroids: are recommended to reduce the pulmonary arteritis and risk/complications associated with pulmonary thromboembolism. There are as yet no studies to evaluate the effect of corticosteroids on the efficacy of melarsomine.
- Adulticide Therapy:
- as for microfilaremic heartworm disease
- Microfilaricide Therapy:
- not required; no microfilaria here
- Preventative Therapy:
- as for microfilaremic heartworm disease